Paul Tudor Jones's MEDP Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 23.0K shares of Medpace Holdings, Inc. (MEDP) worth $11.83 M, representing 0.02% of the portfolio. First purchased in 2016-Q3, this long-term strategic position has been held for 37 quarters.
Based on 13F filings, Paul Tudor Jones has maintained a strategic position in MEDP, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2025, adding 22.7K shares. Largest reduction occurred in Q4 2023, reducing 22.1K shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Medpace Holdings (MEDP) Holding Value Over Time
Track share changes against reported price movement
Quarterly Medpace Holdings (MEDP) Trades by Paul Tudor Jones
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2016 | +9,895 | New Buy | 9,895 | $29.81 |
| Q4 2016 | -3,998 | Reduce 40.40% | 5,897 | $36.12 |
| Q1 2017 | +967 | Add 16.40% | 6,864 | $29.87 |
| Q2 2017 | +5,559 | Add 80.99% | 12,423 | $28.98 |
| Q3 2017 | -1,778 | Reduce 14.31% | 10,645 | $31.94 |
| Q4 2017 | -3,711 | Reduce 34.86% | 6,934 | $36.20 |
| Q1 2018 | -6,934 | Sold Out | 6,934 | $0.00 |
| Q2 2018 | +6,740 | New Buy | 6,740 | $43.03 |
| Q3 2018 | +19,718 | Add 292.55% | 26,458 | $59.91 |
| Q4 2018 | -26,458 | Sold Out | 26,458 | $0.00 |
| Q2 2020 | +19,896 | New Buy | 19,896 | $93.03 |
| Q3 2020 | -15,082 | Reduce 75.80% | 4,814 | $111.76 |
| Q4 2020 | -4,814 | Sold Out | 4,814 | $0.00 |
| Q4 2021 | +3,022 | New Buy | 3,022 | $217.74 |
| Q1 2022 | -3,022 | Sold Out | 3,022 | $0.00 |
| Q4 2022 | +4,951 | New Buy | 4,951 | $0.21 |
| Q1 2023 | +15,269 | Add 308.40% | 20,220 | $0.19 |
| Q2 2023 | +10,245 | Add 50.67% | 30,465 | $240.17 |
| Q3 2023 | -1,301 | Reduce 4.27% | 29,164 | $242.13 |
| Q4 2023 | -22,138 | Reduce 75.91% | 7,026 | $306.53 |
| Q1 2024 | -5,883 | Reduce 83.73% | 1,143 | $404.15 |
| Q2 2024 | -1,143 | Sold Out | 1,143 | $0.00 |
| Q2 2025 | +23,814 | New Buy | 23,814 | $313.86 |
| Q3 2025 | -804 | Reduce 3.38% | 23,010 | $514.16 |
Paul Tudor Jones's Medpace Holdings Investment FAQs
Paul Tudor Jones first purchased Medpace Holdings, Inc. (MEDP) in Q3 2016, acquiring 9,895 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Medpace Holdings, Inc. (MEDP) for 37 quarters since Q3 2016. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones's largest addition to Medpace Holdings, Inc. (MEDP) was in Q2 2025, adding 23,814 shares worth $7.47 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 23,010 shares of Medpace Holdings, Inc. (MEDP), valued at approximately $11.83 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Medpace Holdings, Inc. (MEDP) represents approximately 0.02% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones's peak holding in Medpace Holdings, Inc. (MEDP) was 30,465 shares, as reported at the end of Q2 2023. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.